The Role of Lung and Diaphragm Ultrasonography in Predicting Clinical Progression in Hypoxemic Respiratory Failure
1 other identifier
observational
91
1 country
2
Brief Summary
The goal of this observational study is to evaluate whether the risk of intubation in patients with hypoxemic respiratory failure who were monitored in the intensive care unit and received non-invasive mechanical ventilation and high-flow nasal oxygen treatment could be predicted using lung and diaphragm ultrasound. The main question it aims to answer is: Can lung and diaphragm ultrasound predict the risk of intubation in patients with hypoxemic respiratory failure?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2024
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 23, 2024
CompletedFirst Submitted
Initial submission to the registry
November 11, 2024
CompletedFirst Posted
Study publicly available on registry
November 27, 2024
CompletedNovember 27, 2024
November 1, 2024
4 months
November 11, 2024
November 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Lung and diaphragm ultrasound evaluation for risk of intubation
Lung and diaphragm ultrasound can predict risk of intubation
48 hours
Secondary Outcomes (2)
ROX index evaluation for risk of intubation
48 hours
LUSS/ROX index ratio evaluation for risk of intubation
48 hours
Study Arms (1)
Hypoxemic
Patients whose partial oxygen levels are low
Eligibility Criteria
Hypoxemic patients in intensive care unit
You may qualify if:
- PaO2 \<60 mmHg detected in arterial blood gas samples at the time of admission to the intensive care unit
You may not qualify if:
- Under the age of 18
- History of lung and diaphragm surgery
- Congenital, acquired or traumatic diaphragmatic hernia
- Diaphragm paralysis
- Hemodynamic instability requiring vasoactive drug support
- Do not agree to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Simge Evrenlead
Study Sites (2)
Prof. Dr. Cemil Tascıoglu City Hospital
Istanbul, Şişli, 34384, Turkey (Türkiye)
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Istanbul, Şişli, 34384, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Namigar Turgut
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 11, 2024
First Posted
November 27, 2024
Study Start
January 1, 2024
Primary Completion
May 1, 2024
Study Completion
August 23, 2024
Last Updated
November 27, 2024
Record last verified: 2024-11